Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Ottawa Hospital Research Institute at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Ottawa Hospital Research Institute brings 6 presentations to ASH 2026 in New Orleans. Its program centres on blood clots and bleeding. Research covers JAK2 clonal hematopoiesis after a first clot, clots linked to cancer and pregnancy-related clots in Ontario.

OrganizationASH 2026 Attendance
Universities & research institutes
Research institute of The Ottawa Hospital, affiliated with the University of Ottawa.
Session
Fri Dec 11
3:04pm–4:25pm
Translational Studies in Cancer-Associated Thrombosis
How immune checkpoint drugs, extracellular vesicles, tumor-vessel contact and metabolism push cancer patients toward forming blood clots.
Clotting
Talk
Sun Dec 13
4:30pm–5:45pm
Clones and Clots: Clonal Hematopoiesis in the Management of Venous Thromboembolism
Whether clonal hematopoiesis predicts blood clots in veins, their recurrence and bleeding on blood thinners, and what that means for anticoagulation decisions.
Clotting · Blood biology

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Ottawa Hospital Research Institute

Tell us what you sell and we’ll find the people at Ottawa Hospital Research Institute most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction